Extract notice to the Minister
Gazyva (lymphome folliculaire)
Common name / Subject : obinutuzumab
Name of the manufacturer : Roche
Form : Sol. Perf. I.V.
Dosage : 25 mg/mL (40 mL)
Name of the manufacturer : Roche
Form : Sol. Perf. I.V.
Dosage : 25 mg/mL (40 mL)
Indication : Traitement du lymphome folliculaire
INESSS' Recommendation
Refus d’inscription
Minister's decisions
Surseoir à la décision (2018-11-15)
Evaluation published on October 17, 2018